Volume 15, Issue 3 (volume 15, number 3 2023)                   IJDO 2023, 15(3): 139-148 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

KOÇAKGÖL N, KILIÇ M. Diabetic Foot Risk Factors & level in Diabetes People: A Cross-Sectional Study. IJDO 2023; 15 (3) :139-148
URL: http://ijdo.ssu.ac.ir/article-1-814-en.html
SANKO University, Faculty of Health Sciences, Department of Nursing, Gaziantep/Turkey.
Abstract:   (70 Views)
Objective: Determining diabetic foot risk levels and risk factors and treating foot problems is one of the main components of the prevention of diabetic foot ulcers (DFU). This study aimed to determine diabetic foot risk levels and risk factors in diabetic people.
Materials and Methods: This descriptive cross-sectional study included 278 participants during September 2020 to March 2021. The patients' general characteristics, peripheral sensory loss (10 g-Semmes-Weinstein monofilament), foot skin temperature (palpation method) and vascular evaluation (pedal pulses) were examined.
Results: Among 278 patients, 83 cases had DFU. Of those without DFU, 33.3% had risk level 0”, 35.4% had risk level “1”, 23.6% had risk level “2” and 7.7% had risk level “3”. In the regression analysis, male gender [OR= 0.74, 95% CI (0.014-0.338), P= 0.002], education (literate) [OR= 0.38, 95% CI (0.002-0.630), P= 0.022], foot examination by health professional [OR= 0.013, 95% CI (0.001-0.183), P= 0.001], foot deformity [OR= 0.170, 95% CI (0.042-0.679), P< 0.001], foot skin temperature (cold) [OR= 0.003, 95% CI (0.000–0.026), P< 0.001], and pedal pulse [OR= 8.146, 95% CI (1.505-44.081), P< 0.015] were found to have a high effect on diabetic foot development.
Conclusion: The annual DFU rate is 29.8%. Independent risk factors of DFU were gender, education, previous history foot examination, foot skin temperature, pedal pulse and foot deformity. These findings provide support for a multifactorial etiology for DFU.
 
Full-Text [PDF 727 kb]   (47 Downloads)    
Type of Study: Research | Subject: Special
Received: 2023/01/22 | Accepted: 2023/08/8 | Published: 2023/09/30

References
1. Armstrong DG, Boulton AJ, Bus SA. Diabetic foot ulcers and their recurrence. New England Journal of Medicine. 2017;376(24):2367-75.
2. Navarro-Flores E, Cauli O. Quality of life in individuals with diabetic foot syndrome. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 2020;20(9):1365-72.
3. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A, Jackson N, Johnson KE, Ryder CH. The North‐West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community‐based patient cohort. Diabetic medicine. 2002;19(5):377-84.
4. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Annals of medicine. 2017;49(2):106-16.
5. Agrawal R, Ola V, Bishnoi P, Gothwal S, Sirohi P, Agrawal R. Prevalence of micro and macrovascular complications and their risk factors in type-2 diabetes mellitus. Journal of The Association Physicians of India. 2014;62(6):504-8.
6. Assaad-Khalil SH, Zaki A, Rehim AA, Megallaa MH, Gaber N, Gamal H, et al. Prevalence of diabetic foot disorders and related risk factors among Egyptian subjects with diabetes. Primary care diabetes. 2015;9(4):297-303.
7. Formosa C, Gatt A, Chockalingam N. Diabetic foot complications in Malta: prevalence of risk factors. The Foot. 2012;22(4):294-7.
8. Vibha SP, Kulkarni MM, Kirthinath Ballala AB, Kamath A, Maiya GA. Community based study to assess the prevalence of diabetic foot syndrome and associated risk factors among people with diabetes mellitus. BMC endocrine disorders. 2018;18(1):1-9.
9. International Diabetes Federation. (IDF). Diabetes Atlas 2019. https://www.diabetesatlas.org/ Accessed January 18, 2021.
10. Saltoglu N, Kilicoglu O, Baktiroglu S, Osar-Siva Z, Aktas S, Altindas M, et al. Diagnosis, treatment and prevention of diabetic foot wounds and infections: Turkish consensus report. Klimik Journal. 2015;28(1):2-34.
11. Turkey Diabetes Program - TDP 2015-2020. https://extranet.who.int/ncdccs/Data/TUR_D1_T%C3%BCrkiye%20Diyabet%20Program%C4%B1%202015-2020.pdf.
12. Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA, IWGDF Editorial Board. Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes/metabolism research and reviews. 2020;36:e3266.
13. Khalifa WA. Risk factors for diabetic foot ulcer recurrence: a prospective 2-year follow-up study in Egypt. The Foot. 2018;35:11-5.
14. Zou SY, Zhao Y, Shen YP, Shi YF, Zhou HJ, Zou JY, et al. Identifying at-risk foot among hospitalized patients with type 2 diabetes: A cross-sectional study in one Chinese tertiary hospital. Chronic Diseases and Translational Medicine. 2015;1(04):210-6.
15. Huang ZH, Li SQ, Kou Y, Huang L, Yu T, Hu A. Risk factors for the recurrence of diabetic foot ulcers among diabetic patients: a meta‐analysis. International wound journal. 2019;16(6):1373-82.
16. Saleem S, Hayat N, Ahmad I, Ahmad T, Rehan A. Risk factors associated with poor outcome in diabetic foot ulcer patients. Turkish journal of medical sciences. 2017;47(3):826-31.
17. Chellan G, Srikumar S, Varma AK, Mangalanandan TS, Sundaram KR, Jayakumar RV, et al. Foot care practice-The key to prevent diabetic foot ulcers in India. The Foot. 2012;22(4):298-302.
18. Yazdanpanah L, Shahbazian H, Nazari I, Hesam S, Ahmadi F, Cheraghian B, et al. Risk factors associated with diabetic foot ulcer-free survival in patients with diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018;12(6):1039-43.
19. Al-Ayed MY, Ababneh M, Robert AA, Salman A, Al Saeed A, Al Dawish MA. Evaluation of risk factors associated with diabetic foot ulcers in Saudi Arabia. Current diabetes reviews. 2019;15(3):224-32.
20. Kishore S, Upadhyay AD, Jyotsna VP. Categories of foot at risk in patients of diabetes at a tertiary care center: Insights into need for foot care. Indian journal of endocrinology and metabolism. 2015 May;19(3):405-10.
21. Aboelezz GA, Bahaa El Din RM, Refaat DO. Assesment of diabetic foot Risk factor among patients with diabetes attending to zagazig university hospital. Zagazig University Medical Journal. 2021;27(1):155-65.
22. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. European journal of epidemiology. 2013;28:169-80.
23. Yazdanpanah L, Nasiri M, Adarvishi S. Literature review on the management of diabetic foot ulcer. World journal of diabetes. 2015;6(1):37.
24. American Diabetes Association. 11. Microvascular complications and foot care: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Supplement_1):S151-67.
25. Bus SA, Lavery LA, Monteiro‐Soares M, Rasmussen A, Raspovic A, Sacco IC, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes/metabolism research and reviews. 2020;36:e3269.
26. Registered Nurses' Association of Ontario. Assessment and management of foot ulcers for people with diabetes. Registered Nurses' Association of Ontario= l'Association des infirmières et infirmiers autorisés de l'Ontario; 2013.
27. Biçer EK, Enç N. Validity and reliability of the Turkish adaptation of the foot self care behaviour scale. Diyabet, Obezite ve Hipertansiyonda Hemşirelik Forumu Dergisi. 2014;6(2):35-9.
28. Kishore S, Upadhyay AD, Jyotsna VP. Categories of foot at risk in patients of diabetes at a tertiary care center: Insights into need for foot care. Indian journal of endocrinology and metabolism. 2015;19(3):405.
29. Bakker K, Apelqvist J, Lipsky BA, Van Netten JJ, Schaper NC, International Working Group on the Diabetic Foot (IWGDF). The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence‐based global consensus. Diabetes/metabolism research and reviews. 2016;32:2-6.
30. Al-Maskari F, El-Sadig M. Prevalence of risk factors for diabetic foot complications. BMC family practice. 2007;8(1):1-9.
31. Armstrong DG, Fisher TK, Lepow B, et al. Pathophysiology and Principles of Management of the Diabetic Foot. In: Fitridge R, Thompson M, editors. Mechanisms of Vascular Disease: A Reference Book for Vascular Specialists [Internet]. Adelaide (AU): University of Adelaide Press; 2011. 26.Available from: https://www.ncbi.nlm.nih.gov/books/NBK534268/.
32. Salameh BS, Abdallah J, Naerat EO. Case-control study of risk factors and self-care behaviors of foot ulceration in diabetic patients attending primary healthcare services in palestine. Journal of Diabetes Research. 2020;2020:7624267.
33. Nongmaithem M, Bawa AP, Pithwa AK, Bhatia SK, Singh G, Gooptu S. A study of risk factors and foot care behavior among diabetics. Journal of family medicine and primary care. 2016;5(2):399.
34. Boyko EJ, Monteiro-Soares M, Wheeler SG. Peripheral arterial disease, foot ulcers, lower extremity amputations, and diabetes. Diabetes in America. 3rd edition. 2018. Available from: https://www.ncbi.nlm.nih.gov/books/NBK567977/
35. Lavery LA, Higgins KR, Lanctot DR, Constantinides GP, Zamorano RG, Athanasiou KA, et al. Preventing diabetic foot ulcer recurrence in high-risk patients: use of temperature monitoring as a self-assessment tool. Diabetes care. 2007;30(1):14-20.
36. Crawford F, Cezard G, Chappell FM, Podus group, Young MJ, Abbott CA, et al. The development and validation of a multivariable prognostic model to predict foot ulceration in diabetes using a systematic review and individual patient data meta‐analyses. Diabetic Medicine. 2018 ;35(11):1480-93.
37. Abdissa D, Adugna T, Gerema U, Dereje D. Prevalence of diabetic foot ulcer and associated factors among adult diabetic patients on follow-up clinic at Jimma Medical Center, Southwest Ethiopia, 2019: an institutional-based cross-sectional study. Journal of diabetes research. 2020;2020 :4106383. [DOI:10.1155/2020/9562920]

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Diabetes and Obesity

Designed & Developed by : Yektaweb